Growth factors as mediators of androgen action during male urogenital development

Prostate

Volumn 28, Issue 3 SUPPL. 6, 1996, Pages 22-25

  Cunha, Gerald R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cell cell interactions; epithelial differentiation; epithelium; growth factors; keratinocyte growth factor; mesenchyme; stroma

Indexed keywords

CELL SURFACE RECEPTOR; GROWTH FACTOR RECEPTOR; KERATINOCYTE GROWTH FACTOR;

CELL INTERACTION; CONFERENCE PAPER; EXTRACELLULAR MATRIX; MORPHOGENESIS; PRIORITY JOURNAL; PROSTATE; SEMINAL VESICLE DISEASE; SEXUAL DEVELOPMENT; UROGENITAL SYSTEM;

EID: 0029881816     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0045(1996)6+<22::aid-pros5>3.0.co;2-m     Document Type: Conference Paper

References (33)

1. Cunha GR, Alarid ET, Turner T, Donjacour AA, Boutin EL, Foster BA: Normal and abnormal development of the male urogenital tract: Role of androgens, mesenchymal-epithelial interactions and growth factors. J Androl 13:465-475, 1992.
2. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y: The endocrinology and developmental biology of the prostate. Endocrine Rev 8:338-363, 1987.
3. Higgins SJ, Young P, Cunha GR: Induction of functional cytodifferentiation in the epithelium of tissue recombinants. II. Instructive induction of Wolffian duct epithelia by neonatal seminal vesicle mesenchyme. Development 106:235-250, 1989.
4. Cunha GR, Young P, Higgins SJ, Cooke PS: Neonatal seminal vesicle mesenchyme induces a new morphological and functional phenotype in the epithelia of adult ureter and ductus deferens. Development 111: 145-158, 1991.
5. Wilson JD: Syndrome of androgen resistance. Biol Reprod 46:168-173, 1992.
6. Cunha GR, Young P: Inability of Tfm (testicular feminization) epithelial cells to express androgen-dependent seminal vesicle secretory proteins in chimeric tissue recombinants. Endocrinology 128:3293-3298, 1991.
7. Donjacour AA, Cunha GR: Assessment of prostatic protein secretion in tissue recombinants made of urogenital sinus mesenchyme and urothelium from nor-mal or androgen-insensitive mice. Endocrinology 131: 2342-2350, 1993.
8. Story MT: Polypeptide modulators of prostatic growth and development. In Isaacs JT (eds): "Prostate Cancer: Cell and Molecular Mechanisms in Diagnosis and Treatment." Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1991, pp 123-146.
9. Steiner MS: Role of peptide growth factors in the prostate: A review. Urology 42:99-110, 1993.
10. Shima H, Tsuji M, Young PF, Cunha GR: Postnatal growth of mouse seminal vesicle is dependent on 5α-dihydrotestosterone. Endocrinology 127:3222-3233, 1990.
11. Sugimura Y, Cunha GR, Hayward S, Haysahi N, Arima K, Kawamura J, Rubin J, Aaronson S: Keratinocyte growth factor (KGF) is a mediator of testosterone-induced prostatic development. Mol Cell Diff 1:423, 1993.
12. Aaronson SA, Bottaro DP, Miki T, Ron D, Finch PW, Fleming TP, Ahn J, Taylor WG, Rubin JS: Keratinocyte growth factor: A fibroblast growth factor family member with unusual target cell specificity. Ann NY Acad Sci 638:62-77, 1991.
13. Finch PW, Rubin JS, Miki T, Ron D, Aaronson SA: Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 245:752-755, 1989.
14. Yan GC, Nikolaropoulos S, Wang F, McKeehan WL: Sequence of rat keratinocyte growth factor (heparin-binding growth factor type 7). In Vitro Cell Dev Biol 27A:437-438, 1991.
15. Miki T, Bottaro DP, Fleming TP, Smith CL, Burgess WH, Chan AM-L, Aaronson SA: Determination of ligand-binding specificity by alternative splicing: Two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci USA 89:246-251, 1992.
16. Bottaro DP, Rubin JS, Ron D, Finch PW, Florio C, Aaronson SA: Characterization of the receptor for keratinocyte growth factor. Evidence for multiple fibroblast growth factor receptors. J Biol Chem 265:12767-12770, 1990.
17. Orr-Urtreger A, Bedford MT, Burakova T, Arman E, Zimmer Y, Yayon A, Givol D, Lonai P: Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev Biol 158:475-486, 1993.
18. Marchese C, Rubin J, Ron D, Faggioni A, Torrisi MR, Messina A, Frati L, Aaronson SA: Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: Differentiation response distinguishes KGF from EGF family. J Cell Physiol 144: 326-332, 1990.
19. Werner S, Peters KG, Longaker MT, Fuller PF, Banda MJ, Williams LT: Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc Natl Acad Sci USA 89:6896-6900, 1992.
20. Mason IJ, Pace FF, Smith R, Dickson C: FGF-7 (keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalization and epithelial-mesenchymal interactions. Mech Dev 15:15-30, 1994.
21. Roberts AB, Sporn MB: The transforming growth factor-betas. In Sporn MB, Roberts AB (eds): "Peptide Growth Factors and their Receptors." Heidelberg: Springer-Verlag, 1990, pp 419-472.
22. Kyprianou N, Marrikainen P, Davis L, English HF, Is-sacs JT: Programmed cell death as a new target for prostatic cancer therapy. In Isaacs JT (eds): "Prostate Cancer: Cell and Molecular Mechanisms in Diagnosis and Treatment." Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1991, pp 265-278.
23. Shain SA, Lin AL, Koger JD, Karaganis AG: Rat prostate cancer cells contain functional receptors for transforming growth factor-beta. Endocrinology 126:818-825, 1990.
24. Timme TL, Truong LD, Merz VW, Krebs T, Kadmon D, Flanders KC, Park SH, Thompson TC: Mesenchmal-epithelial interactions and transforming growth factor-b expression during mouse prostate morphogenesis. Endocrinology 134:1039-1045, 1994.
25. 1 on androgen-induced development of neonatal mouse seminal vesicles in vitro. Endocrinology 134:1155-1162, 1994.
26. Silberstein GB, Daniel CW: Reversible inhibition of mammary gland growth by transforming growth factor-beta. Science 237:291-293, 1987.
27. 1-Induced inhibition of mouse mammary ductal growth: developmental specificity and characterization. Dev Biol 135:20-30, 1989.
28. Robinson SD, Silberstein GB, Roberts AB, Flanders KC, Daniel CW: Regulated expression and growth inhibitory effects of transforming growth factor-β isoforms in mouse mammary gland development. Development 113:867-878, 1991.
29. Alarid ET, Rubin JS, Young P, Chedid M, Ron D, Aaronson SA, Cunha GR: Keratinocyte growth factor functions in epithelial induction during seminal vesicle development. Proc Natl Acad Sci USA 91:1074-1078, 1994.
30. Cunha GR, Foster BA, Donjacour A, Rubin JS, Sugimura Y, Finch PW, Brody JR, Aaronson SA: Keratinocyte growth factor: A mediator of mesenchymal-epithelial interactions in the development of androgen target organs. In Motta M, Serio L (eds): "Sex Hormones and Antihormones in Endocrine Dependent Pathology: Basic and Clinical Aspects." New York: Elsevier, 1994, pp 45-57.
31. Rubin JS, Peehl DM, Chedid M, Alarid ET, Cunha GR, Ron D, Aaronson SA: KGF is a paracrine mediator of epithelial cell growth and development in the male reproductive tract. In Second International Symposium on the Biology of Prostatic Growth, NIH publication 14:1992.
32. Yan G, Fukabori Y, McBride G, Nikolaropolous S, McKeehan W: Exon switching and activation of stromal and embryonic FGF/FGF receptor genes in prostate epithelial cells accompanies stromal independence and malignancy. Mol Cell Biol 13:4513-4522, 1993.
33. Hayward SW, Dahiya R, Cunha GR, Bartek J, Despande N, Narayan P: Establishment and characterization of an immortalized but non-tumorigenic human prostate epithelial cell line: BPH-1. In Vitro 31A:14-24, 1995.